Cargando…

Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy

OBJECTIVES: To associate coronary wall volume and composition, derived from coronary computed tomography angiography (CTA), with cardiac allograft vasculopathy (CAV) detected on invasive coronary angiography (ICA) in heart-transplanted (HTX) patients. METHODS: We included consecutive adults who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Foldyna, Borek, Sandri, Marcus, Luecke, Christian, Garbade, Jens, Gohmann, Robin, Hahn, Jochen, Fischer, Julia, Gutberlet, Matthias, Lehmkuhl, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338811/
https://www.ncbi.nlm.nih.gov/pubmed/32179995
http://dx.doi.org/10.1007/s00330-019-06653-3
_version_ 1783554765177749504
author Foldyna, Borek
Sandri, Marcus
Luecke, Christian
Garbade, Jens
Gohmann, Robin
Hahn, Jochen
Fischer, Julia
Gutberlet, Matthias
Lehmkuhl, Lukas
author_facet Foldyna, Borek
Sandri, Marcus
Luecke, Christian
Garbade, Jens
Gohmann, Robin
Hahn, Jochen
Fischer, Julia
Gutberlet, Matthias
Lehmkuhl, Lukas
author_sort Foldyna, Borek
collection PubMed
description OBJECTIVES: To associate coronary wall volume and composition, derived from coronary computed tomography angiography (CTA), with cardiac allograft vasculopathy (CAV) detected on invasive coronary angiography (ICA) in heart-transplanted (HTX) patients. METHODS: We included consecutive adults who received ICA and coronary CTA for evaluation of CAV ≥ 10 months after HTX. In all coronary segments, we assessed lumen and wall volumes and segmental length, calculated volume-length ratio (VLR) (volumes indexed by segmental length; mm(3)/mm), wall burden (WB) (wall/wall + lumen volumes; %), and assessed proportions of calcified, fibrotic, fibro-fatty, and low-attenuation tissue (%) in coronary wall. We rendered independent CTA measures associated with CAV by ICA, tested their discriminatory capacity, and assessed concordance between CTA and ICA. RESULTS: Among 50 patients (84% men; 53.6 ± 11.9 years), we analyzed 632 coronary segments. Mean interval between HTX and CTA was 6.7 ± 4.7 years and between ICA and CTA 1 (0–1) day. Segmental VLR, WB, and proportion of fibrotic tissue were independently associated with CAV (OR = 1.06–1.27; p ≤ 0.002), reaching a high discriminatory capacity (combination of all three: AUC = 0.84; 95%CI, 0.75–0.90). Concordance between CTA and ICA was higher in advanced CAV (88%) compared with that in none (37%) and mild (19%) CAV. Discordance was primarily driven by a large number of segments with coronary wall changes on CTA but without luminal stenoses on ICA (177/591; 25%). CONCLUSION: CTA-derived coronary wall VLR, WB, and the proportion of fibrotic tissue are independent markers of CAV. Combination of these three parameters may aid the detection of early CAV not detected by ICA, the current standard of care. KEY POINTS: • Coronary CTA detects CAV in HTX patients. • Coronary wall volume-length ratio, wall burden, and proportion of fibrotic tissue are independently associated with CAV. • In contrast to ICA, coronary CTA may identify the early stages of CAV. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06653-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7338811
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73388112020-07-09 Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy Foldyna, Borek Sandri, Marcus Luecke, Christian Garbade, Jens Gohmann, Robin Hahn, Jochen Fischer, Julia Gutberlet, Matthias Lehmkuhl, Lukas Eur Radiol Cardiac OBJECTIVES: To associate coronary wall volume and composition, derived from coronary computed tomography angiography (CTA), with cardiac allograft vasculopathy (CAV) detected on invasive coronary angiography (ICA) in heart-transplanted (HTX) patients. METHODS: We included consecutive adults who received ICA and coronary CTA for evaluation of CAV ≥ 10 months after HTX. In all coronary segments, we assessed lumen and wall volumes and segmental length, calculated volume-length ratio (VLR) (volumes indexed by segmental length; mm(3)/mm), wall burden (WB) (wall/wall + lumen volumes; %), and assessed proportions of calcified, fibrotic, fibro-fatty, and low-attenuation tissue (%) in coronary wall. We rendered independent CTA measures associated with CAV by ICA, tested their discriminatory capacity, and assessed concordance between CTA and ICA. RESULTS: Among 50 patients (84% men; 53.6 ± 11.9 years), we analyzed 632 coronary segments. Mean interval between HTX and CTA was 6.7 ± 4.7 years and between ICA and CTA 1 (0–1) day. Segmental VLR, WB, and proportion of fibrotic tissue were independently associated with CAV (OR = 1.06–1.27; p ≤ 0.002), reaching a high discriminatory capacity (combination of all three: AUC = 0.84; 95%CI, 0.75–0.90). Concordance between CTA and ICA was higher in advanced CAV (88%) compared with that in none (37%) and mild (19%) CAV. Discordance was primarily driven by a large number of segments with coronary wall changes on CTA but without luminal stenoses on ICA (177/591; 25%). CONCLUSION: CTA-derived coronary wall VLR, WB, and the proportion of fibrotic tissue are independent markers of CAV. Combination of these three parameters may aid the detection of early CAV not detected by ICA, the current standard of care. KEY POINTS: • Coronary CTA detects CAV in HTX patients. • Coronary wall volume-length ratio, wall burden, and proportion of fibrotic tissue are independently associated with CAV. • In contrast to ICA, coronary CTA may identify the early stages of CAV. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06653-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-03-16 2020 /pmc/articles/PMC7338811/ /pubmed/32179995 http://dx.doi.org/10.1007/s00330-019-06653-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Cardiac
Foldyna, Borek
Sandri, Marcus
Luecke, Christian
Garbade, Jens
Gohmann, Robin
Hahn, Jochen
Fischer, Julia
Gutberlet, Matthias
Lehmkuhl, Lukas
Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title_full Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title_fullStr Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title_full_unstemmed Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title_short Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
title_sort quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
topic Cardiac
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338811/
https://www.ncbi.nlm.nih.gov/pubmed/32179995
http://dx.doi.org/10.1007/s00330-019-06653-3
work_keys_str_mv AT foldynaborek quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT sandrimarcus quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT lueckechristian quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT garbadejens quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT gohmannrobin quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT hahnjochen quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT fischerjulia quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT gutberletmatthias quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy
AT lehmkuhllukas quantitativecoronarycomputedtomographyangiographyforthedetectionofcardiacallograftvasculopathy